We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

143 hedge funds and large institutions have $651M invested in Immunogen Inc in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $1.8M

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

6% less funds holding

Funds holding: 152 → 143 (-9)

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

38% less capital invested

Capital invested by funds: $1.05B → $651M (-$402M)

Holders
143
Holders Change
-9
Holders Change %
-5.92%
% of All Funds
3.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
54
Reduced
34
Closed
26
Calls
$5.14M
Puts
$1.8M
Net Calls
+$3.34M
Net Calls Change
+$2.91M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.74M
2
Fisher Asset Management
Fisher Asset Management
Washington
+$2.07M
3
NC
Nexthera Capital
New York
+$1.93M
4
ClearBridge Investments
ClearBridge Investments
New York
+$1.88M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.76M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.52M
3
Prudential Financial
Prudential Financial
New Jersey
-$2.78M
4
OAM
Oxford Asset Management
United Kingdom
-$2.36M
5
CIP
Convergence Investment Partners
Florida
-$1.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
151
Renaissance Technologies
New York
– -$516K -38,040 Closed
Millennium Management
152
Millennium Management
New York
– -$420K -30,926 Closed
Squarepoint
153
Squarepoint
New York
– -$327K -24,100 Closed
FAM
154
Fred Alger Management
New York
– -$325K -23,950 Closed
VKH
155
Virtu KCG Holdings
New York
– -$193K -14,243 Closed
SFP
156
Santa Fe Partners
New Mexico
– -$156K -11,480 Closed
FA
157
FDx Advisors
Illinois
– -$145K -10,674 Closed
Walleye Trading
158
Walleye Trading
New York
– -$143K -10,558 Closed
M&T Bank
159
M&T Bank
New York
– -$138K -10,164 Closed
AWMS
160
Advocacy Wealth Management Services
Georgia
– -$14K -1,000 Closed
PG
161
PEAK6 Group
Illinois
– -$8K -577 Closed
PMFA
162
Plante Moran Financial Advisors
Michigan
– -$7K -532 Closed
AIA
163
Allegis Investment Advisors
Idaho
– -$2K -155 Closed
BC
164
Bartlett & Co
Ohio
– -$2K -129 Closed
TRCT
165
Tower Research Capital (TRC)
New York
– -$1K -109 Closed
AFP
166
Ausdal Financial Partners
Iowa
– -$1K -77 Closed
QI
167
QS Investors
New York
– -$1K -21 Closed
3 4 5 6
7

IMGN Hedge Fund Activity: Q1 2016 in Review

143 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2016, worth a combined $651M — down 38% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of IMGN and 19 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 54 added.

The largest buyer was Vanguard Group, adding an estimated $2.74M. The largest seller was Fidelity Investments, cutting an estimated $4.76M.

  • 143 institutional investors held Immunogen Inc (IMGN) as of Q1 2016, down from 152 in Q4 2015.
  • Funds reported $651M of Immunogen Inc stock for Q1 2016, down 38% quarter-over-quarter.
  • 19 funds opened new Immunogen Inc positions in Q1 2016 and 26 closed out, a net change of -7 holders.
  • The largest Immunogen Inc buyer in Q1 2016 was Vanguard Group, an estimated $2.74M added.
  • The largest Immunogen Inc seller in Q1 2016 was Fidelity Investments, an estimated $4.76M sold.

Based on aggregated 13F filings for Q1 2016.